Abbott’s trial arrives in the wake of a growing IVL market. Johnson & Johnson has a FDA-approved technology, gaining access ...
A German medical device manufacturer of defibrillation and patient monitoring systems is on the cusp of concluding a ...
Alcon has signed a definitive merger agreement to acquire Lensar to enhance its portfolio of cataract equipment and technology.
Fiona Barry is the Editor-in-Chief of GlobalData PharmSource’s editorial content. She previously worked as an investigative ...
WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.
The agency has published a list of 24 high-risk infectious diseases as a reference tool for funders and researchers.
Abbott’s CGM device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management.
Aditxt subsidiary Pearsanta has acquired patents associated with adductomics-based DNA damage detection to advance cancer ...
The FDA has granted 510(k) approval for UK-based Huntleigh Healthcare’s Dawes-Redman CTG Analysis for foetal monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results